Patents Assigned to Roche Diabetes Care, Inc.
  • Patent number: 10900957
    Abstract: Methods for detecting an analyte in a body fluid are described as well as devices and systems adapted for performing such methods. In embodiments of the method, a sample of body fluid is applied to a test element having at least one test field including at least one test material that is adapted to change at least one measurable property in the presence of the analyte. The test element further includes a capillary to guide the sample across said test field in a flow direction. The test element also includes first and second measurement locations offset from each other in the flow direction. The measurable property is measured in at least one first measurement location, providing at least one first measurement value, and it is measured in at least one second measurement location, providing at least one second measurement value.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: January 26, 2021
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Joachim Hoenes, Christian Ringemann, Andreas Weller
  • Patent number: 10892040
    Abstract: A method is provided for evaluating a set of measurement data from an oral glucose tolerance test. The method may include calculating a similarity measure that quantifies the similarity between a time profile of the series of measured data of the glucose concentration and a corresponding glucose reference profile. The method may include calculating a further similarity measure that quantifies the similarity between the profile of the series of measured values of the further analyte concentration and the corresponding analyte sample profile, wherein the data set is represented by a point in a vector space that comprises coordinate axes that are formed by the similarity measures, whereby the coordinates of said point contain the calculated values of the similarity measures.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: January 12, 2021
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Arnulf Staib, Ortrud Quarder, Gerhard Werner
  • Patent number: 10888664
    Abstract: An adapter for use with an appliance for administering an injectable product, the adapter serving to create a product connection between a catheter and a product container that can be inserted into the appliance, and including a thread for screwing the adapter to the appliance, a stop for fixing the container in the longitudinal direction of the thread, an attachment piece to which the catheter may be connected, and a product channel that extends through the attachment piece and the thread.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: January 12, 2021
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Peter, Reto Sigrist, Stefan Jost
  • Patent number: 10885512
    Abstract: A BLUETOOTH® enabled computing device is configured to use a “pseudo” device identifier to prevent undesired device interference during BLUETOOTH® pairing.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: January 5, 2021
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Craig L. Carlson
  • Patent number: 10878951
    Abstract: A system and method for analyzing measured blood glucose values is disclosed, wherein the system includes a display device, a memory device, and a processor having program instructions which when executed cause the processor to provide blood glucose measurement information including a plurality of measured blood glucose values collected within a measurement time frame, perform a pre-analysis of the blood glucose measurement information, provide analysis data representing statistical blood glucose level information for the plurality of measured blood glucose values by performing an analysis of the plurality of measured blood glucose values, and provide output analysis data representing the analysis data, wherein the provision of analysis data and/or the provision of output analysis data are performed if, in the step of performing the pre-analysis, at least one of the following control checks is positive a fidelity check, and an adherence check.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: December 29, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Matthias Koehler, Peter Blasberg, Mariusz Tracz
  • Patent number: 10874833
    Abstract: A cradle and methods of using embodiments of the cradle are described. The cradle has a proximal side and a distal side, where the proximal side has a skin attachment member for releasable attachment to a patient's skin. The distal side includes a device attachment member configured to attach an initially separate medical device. The cradle comprises an electronically controlled optical indication device, the electronically controlled optical indication device being configured to provide optical indications to the patient when the cradle is attached to the patient's skin.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: December 29, 2020
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Illai J Gescheit
  • Patent number: 10869625
    Abstract: This disclosure concerns a sampling device and a system for collecting body fluid, comprising a metal lancing unit having a distal tip suitable for piercing skin and a capillary channel extending between the tip and a proximal section of the lancing unit for collecting body fluid; and further comprising a plastic holding unit affixed to the lancing unit for manipulating the lancing unit in order to form an incision in the skin, wherein the holding unit contains a sorbent adapted for sorption of moisture and/or volatile substances to protect the sampling device from degradation prior to use.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: December 22, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Wilhelm Leichner
  • Patent number: 10854333
    Abstract: A method and system for setting time blocks of a repeating time period is disclosed. The method and system may be a part of a healthcare management software system.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: December 1, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Schuyler S. Buck, Morris J. Young, Jason Bush, Christopher Richard Baker, Scott W. Leahy
  • Patent number: 10842425
    Abstract: A method is disclosed for the mask-etching of a piercing element having an elongate shaft, a distally protruding tip, a proximal holding part, and a laterally open collecting channel that collects bodily fluid and extends along the shaft as far as the area of the tip, wherein a side of a double-sided etching mask is applied respectively to the two sides of a substrate and, under the action of an etching agent, the piercing element is formed as a part made by chemical blanking, wherein a channel side of the etching mask is provided with a channel etching slit for unilateral etching of the collecting channel.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: November 24, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Marzellinus Zipfel, Angel Lopez-Mras
  • Patent number: 10806384
    Abstract: A kit for determining a concentration of an analyte in a body fluid is disclosed, the kit comprising: a) a sensor module comprising i. a sensor adapted to determine the concentration; ii. a control device connected to the sensor comprising a data collection device to collect measurement data acquired by the sensor, the control device further comprising a wireless near-field communication device adapted to transmit measurement data, the sensor module comprising a sensor module mechanical interface; b) a data reader module adapted to receive measurement data transmitted by the sensor module via wireless near-field communication, the data reader module comprising at least one data storage device; c) a data transmission module to receive measurement data transmitted by the sensor module via wireless near-field communication, the data transmission module comprising a wireless far-field communication device to transmit the measurement data to an external device.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: October 20, 2020
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Stephan-Michael Frey, Oliver Kube, Wolfgang Heck, Helmut Walter
  • Patent number: 10806387
    Abstract: A medical device and method of making the medical device are disclosed. The medical device includes a sensor having an interconnect. The interconnect has a first conductive layer, an insulation layer, and a second conductive layer separated from the first conductive layer by the insulation layer. An electrical contact is provided that is electrically connected to the second conductive layer and is contactable from the side of the interconnect that opposes the second conductive layer. The electrical contact is provided free of micro-vias. The medical device also includes an electronics assembly having an electrical connector, the electronics assembly configured to mate with the interconnect to establish an electrical connection between the electrical connector and the first conductive layer via the electrical contact.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: October 20, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Sabine Achmann, Marcel Thiele, Sebastian Pankalla, Jonathan Seidel
  • Patent number: 10811129
    Abstract: Configuration software implements techniques for customizing names of insulin delivery profiles with improved patient safety. The techniques include: receiving a string of characters which serve as a name for a given insulin delivery profile, where the insulin delivery profile includes at least one parameter pertaining to insulin delivery by an insulin pump and is one of a plurality of insulin delivery profiles associated with a given patient; normalizing the string of characters in accordance with a rule set; comparing the normalized string of characters with names for each of the plurality of insulin delivery profiles; and updating the name of the given insulin delivery profile in a pump configuration file residing on the configuration device when the normalized string of characters is unique in relation to the names of the plurality of insulin delivery profiles.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: October 20, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Jason M. Bush, Christopher R. Halvorson, Troy L. King, James R. Long, David B. Markisohn, Leon R. Organ, III, Adam R. Scroggin, Kaitlin R. Stinson, Kristin M. Westerfield
  • Patent number: 10809221
    Abstract: Methods are disclosed for measuring an analyte concentration in a fluidic sample. Such methods further allow one to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature or both before providing an analyte concentration. The measurement methods utilize information obtained from test sequences having at least one AC block and at least one pulsed DC block, where pulsed DC block includes at least one recovery potential, and where a closed circuit condition of the electrode system is maintained during the DC block. Also disclosed are devices, apparatuses and systems incorporating the various measurement methods.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: October 20, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Terry A. Beaty, Scott E. Carpenter, Zheng Zheng Pan, Nigel A. Surridge
  • Publication number: 20200323471
    Abstract: Systems, devices and methods for assisting users in locating sources of carb-related food items. A hypoglycemic event is detected via a blood glucose monitoring device and a location of a user's mobile device is detected during the hypoglycemic event. In response to the location of the mobile device being at the user's home, carb-related food items in a refrigerator or carb-related food items purchased within a predefined period of time are displayed on the mobile device. In response to the location of the mobile device being outside of the user's home, locations of a predefined source of carbohydrates outside of the home are displayed on the mobile device.
    Type: Application
    Filed: April 11, 2019
    Publication date: October 15, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Mark Gilmore Mears
  • Patent number: 10803989
    Abstract: A method for monitoring medical data is disclosed, the method being applicable to a system comprising a portable medical device, a mobile communications device, and, optionally, a medical care server. The portable medical device and the mobile communications device each comprise at least one interface for data transfer. The method comprises a step of establishing a download link between the mobile communications device and a download server. The method comprises a step of selecting an appropriate communication software package from a plurality of communication software packages for controlling data transfer between the mobile communications device and the portable medical device from the download server. Further, the method comprises a download step for downloading communication software package from the download server to the mobile communications device and a step of installation of the communication software package on the mobile communications device.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: October 13, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Christoph Cronrath, Fernando Andreu, Alberto Val Vicente
  • Patent number: 10791969
    Abstract: The present disclosure refers to a method for determining a blood glucose level for a patient, the method comprising detecting a present sensor signal in a present continuous interstitial blood glucose measurement for a patient; providing measurement data representing the present sensor signal; providing sensor signal correction data representing a patient-specific signal correction, the sensor signal correction data being determined from a former interstitial blood glucose measurement for the patient and comprising at least one of time delay data representing a patient-specific time delay ?t between a blood glucose value measured in a continuous interstitial blood glucose measurement and a blood glucose reference value measured in a capillary blood glucose measurement, and sensor sensitivity data representing, for the patient, a patient-specific sensor sensitivity for the sensor, determining corrected measurement data representing a corrected present sensor signal by applying the sensor signal correction dat
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: October 6, 2020
    Assignee: ROCHE DIABETES CARE, INC
    Inventors: Guenther Schmelzeisen-Redeker, Nikolaus Schmitt, Christian Ringemann
  • Patent number: 10791993
    Abstract: The application relates to a method for analyzing continuously monitored physiological measurement values of a user, the method being performed in a data processing system and comprising: providing, by a data interface, a set of present physiological measurement values, determining whether a common pattern of values is contained in both the set of present physiological measurement values and a set of historical physiological measurement values, if the common pattern of values is found, requesting the user to provide contextualization for at least the present physiological measurement values of the common pattern of values, receiving contextualization and storing contextualized data. Furthermore, the application relates to a device for analyzing continuously monitored physiological measurement values of a user.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: October 6, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Bernd Steiger, Jürgen Rasch-Menges
  • Publication number: 20200305779
    Abstract: A sampling element (110) for generating a sample of a body fluid is disclosed. The sampling element (110) comprises a housing (114), the) housing having a chamber (122) with at least one puncture element (112) stored therein. A tip (132) of the puncture element (112) is movable through at least one puncture opening (124) of the housing (114) in order to perforate a skin portion of a user. The sampling element (110) further comprises at least one compression element (150), which is adapted to increase a pressure of the body fluid within a body tissue of the user in a region of puncturing when pressed onto the skin portion of the user. The compression element (150) is movably mounted to the housing (114). The sampling element (110) comprises at least one locking mechanism (168) for releasably locking the compression element (150) in at least two positions. The at least two positions comprise a first position (170) and a second position (172), the second position (172) being offset from the first position (170).
    Type: Application
    Filed: April 21, 2020
    Publication date: October 1, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Hans List
  • Publication number: 20200309710
    Abstract: The invention concerns an analyte measuring system comprising a test tape (22) having a plurality of functional elements (20) including a test field (46), a further comprising a meter (12) having a tape drive (24) operable to advance the test tape (22), a light source (30) adapted to illuminate at least one measuring spot at a measuring position, and a measuring engine (32) to receive optical signals from the at least one measuring spot for detection of the analyte in the body fluid. For tape positioning, it is proposed that the measuring engine (32) comprises a signal processor (34) operable to determine if a test field (46) is in the measuring position, said determination comprising an identification of a pre-determined distance between at least two functional elements (20) in the optical signals obtained while advancing the test tape (22).
    Type: Application
    Filed: October 25, 2018
    Publication date: October 1, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Max Berg, Fredrik Hailer
  • Patent number: D899588
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: October 20, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Thomas Z. Harkin